Cencora (NYSE:COR) & AdaptHealth (NASDAQ:AHCO) Head-To-Head Review

AdaptHealth (NASDAQ:AHCO – Get Free Report) and Cencora (NYSE:COR – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Insider & Institutional Ownership

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 1.9% of AdaptHealth shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

AdaptHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.

Valuation and Earnings

This table compares AdaptHealth and Cencora”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AdaptHealth $3.24 billion 0.32 -$70.79 million ($3.00) -2.57
Cencora $638.56 million 106.67 $3.48 billion $17.92 19.92

Cencora has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AdaptHealth and Cencora’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdaptHealth -12.90% -0.27% -0.09%
Cencora 1.03% 110.72% 4.22%

Analyst Ratings

This is a summary of recent recommendations for AdaptHealth and Cencora, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdaptHealth 1 1 7 0 2.67
Cencora 0 4 12 0 2.75

AdaptHealth currently has a consensus price target of $9.43, indicating a potential upside of 22.07%. Cencora has a consensus price target of $368.14, indicating a potential upside of 3.13%. Given AdaptHealth’s higher probable upside, analysts clearly believe AdaptHealth is more favorable than Cencora.

Summary

Cencora beats AdaptHealth on 10 of the 14 factors compared between the two stocks.

About AdaptHealth

(Get Free Report)

AdaptHealth provides home medical equipment, supplies and related services to patients managing chronic conditions and recovering from illness or injury. Its offerings include oxygen and other respiratory equipment, sleep-therapy devices such as CPAP machines, and diabetes supplies, including continuous glucose monitoring products. The company also provides equipment and support for other care needs at home, working with patients, clinicians, hospitals and health plans to help coordinate access to prescribed products and services.

About Cencora

(Get Free Report)

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.